EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 548.06B
Enterprise Value 347.55B
Trailing P/E 63.28
Forward P/E 137.41
PEG Ratio (5 yr expected) 13.30
Price/Sales (ttm)11.58
Price/Book (mrq)12.60
Enterprise Value/Revenue 311.45
Enterprise Value/EBITDA 637.40

Trading Information

Stock Price History

Beta (5Y Monthly) 0.77
52-Week Change 337.38%
S&P500 52-Week Change 325.78%
52 Week High 3247.64
52 Week Low 3163.08
50-Day Moving Average 3235.04
200-Day Moving Average 3224.92

Share Statistics

Avg Vol (3 month) 31.22M
Avg Vol (10 day) 31.38M
Shares Outstanding 5208.57M
Float 207.05M
% Held by Insiders 10.37%
% Held by Institutions 10.00%
Shares Short (Dec. 30, 2019) 42.35M
Short Ratio (Dec. 30, 2019) 41.76
Short % of Float (Dec. 30, 2019) 41.27%
Short % of Shares Outstanding (Dec. 30, 2019) 41.13%
Shares Short (prior month Nov. 28, 2019) 42.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Dec. 13, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin 18.64%
Operating Margin (ttm)28.57%

Management Effectiveness

Return on Assets (ttm)12.43%
Return on Equity (ttm)21.56%

Income Statement

Revenue (ttm)4.15B
Revenue Per Share (ttm)19.94
Quarterly Revenue Growth (yoy)20.70%
Gross Profit (ttm)2.78B
EBITDA 1.27B
Net Income Avi to Common (ttm)773.7M
Diluted EPS (ttm)3.64
Quarterly Earnings Growth (yoy)21.60%

Balance Sheet

Total Cash (mrq)1.36B
Total Cash Per Share (mrq)6.51
Total Debt (mrq)670.7M
Total Debt/Equity (mrq)17.58
Current Ratio (mrq)3.53
Book Value Per Share (mrq)18.30

Cash Flow Statement

Operating Cash Flow (ttm)1.07B
Levered Free Cash Flow (ttm)647.92M